JointPoint Information

JointPoint's patent-pending system provides a surgeon with intraoperative leg length, offset, and cup positioning data when performing total hip replacement. It is designed for use with minimally invasive hip replacement techniques such as DAA (direct anterior approach). The software features technology that guides stem offset and head selection during surgery, with the potential to reduce head trialing and the surgical time associated with it. JointPoint has been cleared by the FDA as a class II medical device and is presently designed for use with hip and knee reconstruction. The system is non-invasive, doesn't require hardware or drilling, and has the potential to reduce surgical time while reducing surgical outliers. For additional information, visit www.JointPoint.com or email us at info@JointPoint.com